Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients

Mediators of Inflammation

Volumn 12, Issue 4, 2003, Pages 209-214

  Hamzaoui, Agnès ^a,b   Ammar, Jamel ^a,b   Graïri, Hédia ^a,b   Hamzaoui, Kamel ^b  

^a ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS   (Tunisia)

Author keywords

Fas; Fas ligand; Inflammation; Silicosis

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL SEPARATION; CLINICAL ARTICLE; CYTOMETRY; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG LAVAGE; LYMPHOCYTE; MALE; MEMORY CELL; NICK END LABELING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SILICOSIS; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; DNA FRAGMENTATION; FAS LIGAND PROTEIN; HUMANS; IN SITU NICK-END LABELING; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; SILICOSIS;

EID: 0142029981     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350310001599648     Document Type: Article

References (36)

1. Garn H, Friedetzky A, Davis GS, Hemenway DR, Gemsa D. T-lymphocyte activation in the enlarged thoracic lymph nodes of rats with silicosis. Am J Respir Cell Mol Biol 1997; 16: 309-316.
2. Ueki A, Isozaki Y, Tomokuni A, et al. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus as well as in healthy individuals. Clin Exp Immunol 2002; 129: 556-561.
3. Ueki A, Kinugawa K, Hyodoh F, Kawakami Y, Sakagushi, Miyahara Y. The role of silica compounds in the autoimmune diseases accompanied by silicosis. Arch Complex Environ Studies 1996; 8: 53-59.
4. + T cells by chrysotile asbestos in vitro. Cancer Lett 1992; 66: 99-106.
5. + lymphocytes can be stimulated by crocidolite, anthophyllite and amosite asbestos in vitro. Int J Oncol 1993; 2: 209-214.
6. Ueki A, Yamaguchi M, Ueki H, Watanabe Y, Ohsawa G, Kinugawa K, Kawakami Y, Hyodoh F. Polyclonal human T-cell activation by silicate in vitro. Immunology 1994; 82: 332-335.
7. Ueki A, Nakashima M, Kishimoto T, Sakaguchi H. Analysis of the expression of TCR Vβ repertoires in patients with silicoses. J Occup Health 1996; 3: 67-69.
8. Tomokuni A, Otsuki T, Isozaka Y, Ueki H, Kusaka M, Ueki A. Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol 1999; 118: 441-444.
9. Otsuki T, Sakaguchi H, Tomokuni A, et al. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 1998; 94: 258-262.
10. McDonald AH. Silicone-containing macrophages prevent activation-induced cell death in murine lymphocytes. Exp Biol 1999 [abstract 847.2].
11. Smalley DL, Shanklin DR, Hall MF. Monocyte-dependent stimulation of human T cells by silicon dioxide. Pathobiology 1998; 66: 302-305.
12. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoroliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-976.
13. Adachi M, Watanabe-Fukungara R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993; 90: 1756-1765.
14. Nakajima T, Aone H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocyte. Arthritis Rheum 1995; 38: 485-491.
15. Firestein GS, Yeo M, zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995; 96: 1631-1038.
16. Hamzaoui K, Hamzaoui A, Zakraoui L, Chabbou A. Levels of soluble Fas/APO-1 in patients with Behçet's disease. Mediat Inflamm 1998; 7: 111-114.
17. Hamzaoui A, Grairi H, Ammar J, Zekri S, Guemira F, Hamzaoui K. IL18 mRNA expression and IFNg induction in bronchoalveolar lavage from Behçet's disease. Clin Exp Rheumatol 2003; 21 (Suppl 30): 29-35.
18. Levesque MC, Haynes BF. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFNγ. J Immunol 2001; 166: 188-196.
19. Hamzaoui K, Hamzaoui A, Hentati F, et al. Phenotype and functional profile of T cells expressing γδ receptor from patients with active Behçet's disease. J Rheumatol 1994; 21: 2301-2306.
20. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
21. Kinoshita T, Imamura J, Nagai H, Shimotohno K. Quantification of gene expression over wide range by the polymerase chain reaction. Anal Biochem 1992; 206: 231-235.
22. Lanzillo J. Chemiluminiescent nuclei acid detection with digoxigenin-labeled probes: a model system with robes for angiotensin converting enzyme which detect less than one attomole of target DNA. Anal Biochem 1991; 194: 45-53.
23. Davis GS, Holmes CE, Pfeiffer LM, Hemenway DR. lymphocytes, lymphokines and silicosis. J Environ Pathol Toxicol Oncol 2001; 1: 53-65.
24. Davis GS, Pfeiffer LM, Hemenway DR. Interferon-γ production by specific lung lymphocyte phenotypes in silicosis in mice. Am J Respir Cell Mol Biol 2000; 22: 491-501.
25. Tomokuri T, Aikoh T, Matsuki T, et al. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumors. Clin Exp Immunol 1997; 110: 303-309.
26. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
27. Takemi OT, Akiko TO, Haruko SA, Fuminori HY, Masayasu KU, Ayako UE. Reduced expression of the inhibitory genes for Fas-mediated apoptosis in silicosis patients. J Occup Health 2000; 42: 163-168.
28. Kägi D, Vagnaux F, Ledermann B, et al. Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528-530.
29. Ashara H, Hasumuna T, Kobata T, et al. Expression of Fas antigen and FasL in the Rheumatoid synovial tissue. Clin Immunol Immunopathol 1996; 81: 27-34.
30. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocyte. Arthritis Rheum 1995; 38: 485-491.
31. + T cells with ageing. Clin Exp Immunol 2000; 120: 267-273.
32. + human T lymphocyte subsets. Eur J Immunol 1993; 23: 61-68.
33. + subsets. J Immunol 1995; 155: 3322-3328.
34. Oka S, Mori N, Matsuyama S, Takamori Y, Kubo K. Presence of B220 within thymocytes and its expression on the cell surface during apoptosis. Immunology 2000; 100: 417-423.
35. + spleen cells. Scand J Immunol 1996; 43: 263-267.
36. Renno T, Attinger A, Rimoldi D, Hahne M, Tschopp J, MacDonald HR. Expression of B220 on activated T cell blasts precede apoptosis. Eur J Immunol 1998; 28: 540-547.